top of page

Our Newsroom

At Mike Tilley Nation Foundation, we believe that information is power and the landscape of cancer is evolving every day. It is imperative that we keep learning as a community in order to learn how we can fight this battle against cancer. Here are some of the latest headlines in Colorectal Cancer.

The annual American Cancer Society report shows colorectal cancer is now the leading cause of cancer death in men and the second in women under 50 years old

Jan 17, 2024

Cancer Mortality Still Declining, but Progress Threatened by Increasing Incidence as Projected New Cancer Cases Top Two Million for 2024

american-cancer-society1726.jpg

When Should You Get Screened for Colon Cancer?

March 24, 2023

Research shows that rates of colorectal cancer are increasing in U.S. adults under the age of 55.
While the recommended screening age is 45, experts say people who are at high risk of colorectal cancer should seek testing sooner.
The presence of certain symptoms might also alert someone to get screened, even if they're younger than 45.

VWH-Screened-for-Colon-Cancer-3-c8625aeb34914c17ab65bd7bcd4a2ace.webp

Ignore The Headlines: Some Kind Of Colorectal Cancer Screening Is Essential To Reducing Deaths

October 11, 2022

A study sought to test the effect of colonoscopy screening on the risks of both colorectal cancer and related deaths over a 10 year period. Findings indicated that colonoscopies for colorectal cancer screening did not have a statistically significant impact on the risk of cancer deaths.

In the trial, the risk of colorectal cancer at 10 years was 18% lower among participants who were invited to undergo screening colonoscopy than among those who were assigned to no screening. However, only 42% of patients randomized to colonoscopy completed the test.


MOST IMPORTANTLY: Among patients who actually got the colonoscopy, there was a 31% decrease in colorectal cancer and a 50% decline in mortality.

10.12.jpg

Health.com: Late-Stage Colorectal Cancer Is on the Rise in Young Adults, New Study Shows

February 02, 2022

The research shows the rate of colorectal cancer cases in young adults has recently soared, and experts advise early screening is key to decreasing it.

image_edited.jpg

USA Today: Late-stage colon cancer showing up in more younger adults. 'Get screened,' doctor urges

January 27, 2022

A growing number of young adults are being diagnosed with late-stage colon cancer, according to a new peer-reviewed study.


The study revealed that young patients ages 20 to 29 have seen the highest spike in rates of diagnosed colon cancer cases. That age group is also more likely to have a distant, less treatable form of cancer when officially diagnosed. That revelation is another reason doctors say screenings are essential. 

2_edited.jpg

NBC News: Could mRNA vaccines be the next frontier of cancer treatment?

December 17, 2021

A clinical trial is enrolling colorectal cancer patients to see whether a personalized mRNA vaccine can prevent their cancer from coming back.

211215-mRNA-cancer-vaccine-mn-1345-b4b22f.jpg

MSK: Young Adults and the Alarming Rise of Colorectal Cancer: New Insights from Memorial Sloan Kettering Experts

Wednesday, August 18, 2021

Could colorectal cancer in people under 50 years old be biologically different and more aggressive than colorectal cancer in older people?


That’s what some researchers have proposed as people in their 20s, 30s, and 40s face a disturbing rise in colorectal cancer — people who are often decades younger than the typical age of patients with the disease.   

damien-scogin-image001-1200x800.jpg

Good Morning America: Cutting-edge Test Detects Early Tumor Recurrence In Some Cancers

June 10, 2021

A new blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating tumor DNA in the bloodstream for certain types of cancers.

"What makes the tumor DNA different is that it has certain mutations that actually lead to the uncontrolled cell growth that became the cancer," Solomon Moshkevich, the general manager of oncology at Natera, told "Good Morning America." "And by virtue of analyzing a sample of the tumor, from the patient, we actually know what the mutations are in that cancer and we know exactly what we're looking for when we go analyzing the blood sample."

natera-ht-ml-210610_1623340058279_hpEmbed_16x9_992.jpg
Our Newsroom: In the Press
bottom of page